News

Explore the Latest Advancements and Updates.

Rollie Carlson on How Cross-Training and Extreme Ownership Help You Advance Your Career

Data Presentation at Association for Molecular Pathology 2023 Validates Performance of SeptiCyte® RAPID in Immunocompromised Patients and Patients on Immunosuppressive Therapy

“Improving Outcomes For Patients With Sepsis” — Interview from Progress, Potential & Possibilities

CHEST 2023 Poster Demonstrates the Utility of SeptiCyte® RAPID in Antibiotic Administration and Sepsis Bundle Compliance

Rollie Carlson joins the Med-Tech podcast to discuss early diagnosis of sepsis

SeptiCyte® RAPID Receives ICD-10-PCS Code from the U.S. Centers for Medicare & Medicaid Services (CMS)

PodcastDX: Richard Brandon on Sepsis Rapid Test

Immunexpress and University Hospitals Cleveland Medical Center Present Quality Improvement Feasibility with SeptiCyte® RAPID at the 2023 American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Lab Expo

In the News: Why Better Sepsis Diagnosis Results in Better Outcomes

Immunexpress Announces Adoption of SeptiCyte® RAPID by FirstHealth of the Carolinas

Slice of Healthcare’s Big Breakthrough podcast features Richard Brandon, Chief Scientific Officer At Immunexpress

In the news: A Diagnostic Dilemma

If you are a member of the media, please contact:

David Schull
Russo Partners, LLC
david.schull@russopartnersllc.com

Maddie Stabinski
Russo Partners, LLC
madeline.stabinski@russopartnersllc.com